Legal Representation
Attorney
Umair A. Qadeer
USPTO Deadlines
Next Deadline
1778 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241105)
Due Date
November 05, 2030
Grace Period Ends
May 05, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 5, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 5, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 20, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 20, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 31, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 11, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 11, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 11, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 11, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 11, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 11, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 11, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 11, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 29, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 29, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 13, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 12, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 15, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Comprehensive clinical laboratory medical testing services, namely, comprehensive cancer related laboratory testing, flow cytometry testing, molecular based testing, cytogenetics testing, fluorescent in situ hybridization (FISH) testing, anatomic pathology testing, immunoassays and clinical chemistry, digital pathology, next-generation sequencing, and minimum residual disease (MRD) testing; Medical diagnostic testing, monitoring and reporting services
First Use Anywhere:
Aug 31, 2022
First Use in Commerce:
Aug 31, 2022
Additional Information
Design Mark
The mark consists of a stylized H formed from two abstract shapes that represent nucleic acid helices oriented vertically.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
044